Denali Therapeutics, Inc. (DNLI)
16.42
-0.16
(-0.93%)
USD |
NASDAQ |
Dec 30, 16:00
16.42
0.00 (0.00%)
After-Hours: 20:00
Denali Therapeutics EPS Diluted (Quarterly): -0.736 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Masimo Corp. | -1.859 |
| Novavax, Inc. | -1.246 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| iRhythm Technologies, Inc. | -0.162 |
| Twist Bioscience Corp. | -0.4491 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -126.90M |
| Total Expenses (Quarterly) | 126.90M |
| Enterprise Value | 1.785B |
| Earnings Yield | -17.72% |
| Normalized Earnings Yield | -17.72 |